Medtronic's Valiant Navion Thoracic Stent Graft System Garners Both FDA and CE Mark Approvals

Only three weeks ago, Medtronic's Valiant Navion ™ Thoracic Stent Graft System received FDA approval. Today, the company announced that its low profile device now has been approved for the CE Mark in Europe as well. According to Medtronic, this lower profile stent graft, which was eight years in the making, now makes it possible to use as a trea tment in the broadest possible patient population, especially in those whose anatomy would not permit thoracic endovascular aneurysm repair (TEVAR), such as patients with narrower or more curved iliac arteries, most commonly female.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news